Publications found:
354
Sort by:
Losartan Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Contract Manufacturing Organizations, In-House), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Losartan market is anticipated to expand from USD 743.21 million in 2025 to USD 933.37 million by 2031, reflecting a compound annual growth rate (CAGR) of 3.87%. As an angiotensin II recept...
May 2026
185 pages
Beta Blockers Market - 2026-2033
US$ 3,400.00
Beta Blockers Marketis is growing with a CAGR of 4.29% during the forecast period 2026-2035. The Beta Blockers Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seaso...
April 2026
39 pages
Global Cardiac Myosin Inhibitors Market Growth 2026-2032
US$ 3,660.00
The global Cardiac Myosin Inhibitors market size is predicted to grow from US$ 815 million in 2025 to US$ 1770 million in 2032; it is expected to grow at a CAGR of 12.0% from 2026 to 2032. In 2025, gl...
April 2026
85 pages
Global Myosin Inhibitors Market Growth 2026-2032
US$ 3,660.00
The global Myosin Inhibitors market size is predicted to grow from US$ 908 million in 2025 to US$ 2058 million in 2032; it is expected to grow at a CAGR of 12.8% from 2026 to 2032. In 2025, global Myo...
April 2026
85 pages
Cardiac Arrest Treatment Market - 2026-2033
US$ 3,400.00
Cardiac Arrest Treatment Marketis is growing with a CAGR of 7.50% during the forecast period 2026-2035. The Cardiac Arrest Treatment Market emerges as a key focus in DataM Intelligence latest in-depth...
April 2026
50 pages
Dilated Cardiomyopathy Therapeutics Market - 2026-2033
US$ 3,400.00
Dilated Cardiomyopathy Therapeutics Marketis is growing with a CAGR of 5.54% during the forecast period 2026-2035. The Dilated Cardiomyopathy Therapeutics Market emerges as a key focus in DataM Intell...
April 2026
61 pages
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 2,999.00
The global congestive heart failure drugs market size reached USD 10.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.6 Billion by 2034, exhibiting a growth rate (CAG...
April 2026
150 pages
Hypercholesterolemia Market Size by Type (Type 1, Type 2A, Type 2B, Type 3, Type 4, Type 5, and Others), Diagnosis and Treatment (Diagnosis, Treatment), Patient (Pediatric, Adults, Geriatric), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), and Region ?2026-2034?
US$ 2,999.00
The global hypercholesterolemia market size reached USD 22.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 65.0 Billion by 2034, exhibiting a growth rate (CAGR) of 12.0...
April 2026
136 pages
Atrial Fibrillation Treatment Market Report by Disorder Type (Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Permanent Atrial Fibrillation, and Others), Treatment Type (Medical Procedures, Medication), End-User (Hospitals, Cardiac Labs, Ambulatory Surgical Centers, and Others), and Region 2026-2034
US$ 2,999.00
The global atrial fibrillation treatment market size reached USD 9.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 21.2 Billion by 2034, exhibiting a growth rate (CAGR)...
April 2026
139 pages
Stroke Management Market Report by Type (Diagnostics, Therapeutics), Application (Ischemic Stroke, Haemorrhagic Stroke, and Others), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others), and Region 2026-2034
US$ 2,999.00
The global stroke management market size reached USD 40.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 65.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.60% d...
April 2026
140 pages
Cardiovascular Therapeutics Drugs Market - 2026-2033
US$ 3,400.00
Cardiovascular Therapeutics Drugs Marketis is growing with a CAGR of 4.00% during the forecast period 2026-2035. The Cardiovascular Therapeutics Drugs Market emerges as a key focus in DataM Intelligen...
March 2026
59 pages
Hypertrophic Cardiomyopathy Therapeutics Market Size, Share & Trends Analysis Report By Drug Class, (Beta Blockers, Calcium Channel Blockers), By Disease Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global hypertrophic cardiomyopathy therapeutics market size was estimated at USD 1.43 billion in 2025 and is projected to reach USD 2.16 billion by 2033, growing at a CAGR of 5.5% from 2026 to 203...
March 2026
150 pages
Global Warfarin Sodium Tablets Market Growth 2026-2032
US$ 3,660.00
The global Warfarin Sodium Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Warfarin is an oral anticoa...
March 2026
82 pages
Global Doxazosin Mesylate Tablets Market Growth 2026-2032
US$ 3,660.00
The global Doxazosin Mesylate Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Doxazosin is commonly us...
March 2026
105 pages
Global Valsartan Capsules Market Growth 2026-2032
US$ 3,660.00
The global Valsartan Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Valsartan capsules are a type of...
March 2026
93 pages
Global Vascular Health Supplements Market Growth 2026-2032
US$ 3,660.00
The global Vascular Health Supplements market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Vascular Health supplem...
March 2026
125 pages
Global Acipimox API Market Growth 2026-2032
US$ 3,660.00
The global Acipimox API market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Acipimox API refers to the pure, activ...
March 2026
88 pages
Global Bempedoic Acid Products Market Growth 2026-2032
US$ 3,660.00
The global Bempedoic Acid Products market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Bempedoic acid products ref...
March 2026
78 pages
Global Bile Acid Resins Market Growth 2026-2032
US$ 3,660.00
The global Bile Acid Resins market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Bile acid resins, also known as bi...
March 2026
138 pages
Global Cholesterol Lowering Drugs Market Growth 2026-2032
US$ 3,660.00
The global Cholesterol Lowering Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Cholesterol-lowering dru...
March 2026
139 pages
Global Gemfibrozil API Market Growth 2026-2032
US$ 3,660.00
The global Gemfibrozil API market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Gemfibrozil API refers to the pure,...
March 2026
110 pages
Global Gemfibrozil Drugs Market Growth 2026-2032
US$ 3,660.00
The global Gemfibrozil Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Gemfibrozil drugs are medications...
March 2026
118 pages
Global Icosapent Ethyl Drugs Market Growth 2026-2032
US$ 3,660.00
The global Icosapent Ethyl Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Icosapent ethyl drugs are a t...
March 2026
129 pages
Global Levosimendan Injection Market Growth 2026-2032
US$ 3,660.00
The global Levosimendan Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Levosimendan injection is a...
March 2026
80 pages
Global Omega-3 Fatty Acid Drugs Market Growth 2026-2032
US$ 3,660.00
The global Omega-3 Fatty Acid Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Omega-3 fatty acid drugs a...
March 2026
144 pages
Global PCSK9 Antagonists Market Growth 2026-2032
US$ 3,660.00
The global PCSK9 Antagonists market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. PCSK9 antagonists are a class of...
March 2026
122 pages
Global Triglyceride Lowering Drugs Market Growth 2026-2032
US$ 3,660.00
The global Triglyceride Lowering Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Triglyceride-lowering d...
March 2026
144 pages
Novel oral anticoagulants (NOACs) Market - 2024-2031
US$ 3,400.00
Novel oral anticoagulants (NOACs) Marketis is growing with a CAGR of 10.20% during the forecast period 2026-2035. The Novel oral anticoagulants (NOACs) Market emerges as a key focus in DataM Intellige...
February 2026
59 pages
Hypercholesterolemia Treatment Market - 2025-2033
US$ 3,400.00
Hypercholesterolemia Treatment Market reached US$ 20.34 billion in 2024 and is expected to reach US$ 57.18 billion by 2033, growing with a CAGR of 11.70% during the forecast period 2026-2033. The Hype...
February 2026
56 pages
India Statin Market Size, Share, Trends and Forecast by Type, Therapeutic Area, Drug Class, Application, Distribution, and Region, 2026-2034
US$ 2,999.00
The India statin market size reached USD 534.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 676.6 Million by 2034, exhibiting a growth rate (CAGR) of 2.66% during 2026...
February 2026
141 pages
